GPD1 and glioblastoma: Scientists have demonstrated that aberrant GPD1 expression is found in dormant GSCs, but not in NSCs in vivo, and its expression could aggravate the progression of GBM due to its significance for GSC proliferation and maintenance, furnishing dormant GSCs with functional correlation as a therapeutic target (102).